Health Condition 1: null- Male and female overweight or obese subjects with BMI of 25-30 in the age group of 18-60 years
Conditions
Interventions
Intervention1: CGA-7: Coffea Arabica
Control Intervention1: Placebo: Maltodextrin
Sponsors
Vidya Herbs Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who are willing to give written informed consent. 2. Patient is willing and able to comply with all trial requirements 3. Overweight or obese; BMI between 25-30
Exclusion criteria
Exclusion criteria: • Subjects with BMI >30 • Cigarette smoker, History of heart, liver and kidney disease, hypertension, pregnancy, lactating, Type 1 diabetes and weight loss medication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Reduction in body weight and BMI at week 4, 8 and 12 of treatment 2.Muscle mass-fat mass ratio, body fat (%) Timepoint: 1.Reduction in body weight and BMI at week 4, 8 and 12 of treatment 2.Muscle mass-fat mass ratio, body fat (%) at visit 1 (Day 1) and final visit (12th week) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Changes in lipid profile (Triglycerides, cholesterol, HDL and LDL) 2.Blood pressure 3.Changes in anthropometric measurements â?? Waist and hip circumference; Waist-hip ratio 4.Quality of life of subjects before and after treatment 5.Incidence and rate of adverse events Timepoint: 12 weeks | — |
Countries
India
Contacts
Public ContactDr Supreeth
Sri Kalabyraveswara Swamy Ayurvedic Medical College, Hospital and Research Centre
Outcome results
None listed